Interventional Cardiology Market Size, Share and Opportunities 2023

The global interventional cardiology market size was valued at USD 19,274.6 million in 2022 and is poised to grow at a significant CAGR of 9.0% during the forecast period 2023-29. The primary drivers of the expansion of the global interventional cardiology market include the increasing prevalence of cardiac disease and increase in number of geriatric population. Furthermore, the increase in tobacco consumption and increase in obesity among population is expected to push the market growth.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/interventional-cardiology-market

The interventional cardiology market is segmented based on product type, end users, and geography.

Based on the product type, the market is segmented into the following:
• Coronary Stents
• Catheters
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
• Endovascular Aneurysm Repair Stent Grafts
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Others

Based on the end user, the market is segmented into the following:
• Hospitals
• Cardiac Catheterization Laboratories
• Ambulatory Surgical Centers
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Coronary Stents Segment is expected to Dominate the Interventional Cardiology Market:
Based on the Product type, the global Interventional Cardiology market is segmented into Coronary Stents, Catheters, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons, PTCA Guide Wires, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices And Others. The coronary stents segment is expected to account for a larger revenue share in the global interventional Cardiology market. The advancement in coronary stents is expected to drive the market growth in this segment. The newly launched stents like bioabsorbable stents, drug eluting coronary stents are in high demand in the market. In drug eluting stent, the stent is coated with a thin layer of medication which releases in the blood slowly to prevent the growth of the scar tissue in artery lining.

North America Interventional Cardiology Market
The North America interventional Cardiology market is expected to increase over the forecast period due to the increased affordability of the people in this region, well developed healthcare infrastructure. In addition, the government in the countries like Canada and USA supports the key market player in product development and research in this region. North America is the highest consumer of interventional cardiology devices in the historic years and thus expected to dominate the global interventional cardiology market. Asia Pacific and Europe region are expected to have a significant growth in interventional cardiology market in the forecasted years.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.

The global Interventional Cardiology market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In July 2021, Abbott launched its product XIENCE family of stents, which got USFDA's approval for one month DAPT labeling for patients with high bleeding risk in US.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=122953

Key players profiles in the Interventional Cardiology Market report are ABIOMED Inc., ACIST Medical Systems, B. Braun Melsungen AG, Biotronik SE & Co., Boston Scientific Corporation, Cardinal Health, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic, Merit Medical Systems, Koninklijke Philips N.V., Abbott, Terumo Corporation, Rontis Corporation Inc., Biosensors International Group Ltd.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.